This study aimed to evaluate the impact of sarcopenia and frailty on the quality of life of older hemodialysis patients.
Methods:
Seventy hemodialysis patients aged ⩾60 years were assessed. Daily living activities (Katz Index), depression (Yesavage Scale), frailty (Fried’s Criteria), and sarcopenia (EWGSOP2) were evaluated. Quality of life was measured using the KDQOL-36 questionnaire.
Results:
The median age was 67 years, and 50% were female. Nineteen patients (27.1%) were partially dependent, 71.4% were pre-frail, and 15.7% were frail. Probable sarcopenia was detected in 77.1%, and sarcopenia in 8.6% of patients. Sarcopenia was associated with older age, higher dependency, depression, lower income, and frailty (p < 0.05). It was also related to the KDQOL-36 physical component (p = 0.031), while frailty correlated with the symptom component (p = 0.047).
Conclusion:
Frailty and sarcopenia are common in older hemodialysis patients and adversely affect their quality of life.
CoreshJAstorBCGreeneT, et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis2003; 41: 1–12.
2.
WebsterACNaglerEVMortonRL, et al. Chronic kidney disease. Lancet2017; 389: 1238–1252.
3.
Bischoff-FerrariHAOravJEKanisJA, et al. Comparative performance of current definitions of sarcopenia against the prospective incidence of falls among community-dwelling seniors age 65 and older. Osteoporos Int2015; 26: 2793–2802.
4.
CheungCLLamKSCheungBM.Evaluation of cutpoints for low lean mass and slow gait speed in predicting death in the national health and nutrition examination survey 1999–2004. J Gerontol A Biol Sci Med Sci2016; 71: 90–95.
5.
BaumgartnerRNWayneSJWatersDL, et al. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes Res2004; 12: 1995–2004.
6.
BeaudartCZaariaMPasleauF, et al. Health outcomes of sarcopenia: a systematic review and meta-analysis. PLoS One2017; 12: e0169548.
7.
SousaASGuerraRSFonsecaI, et al. Financial impact of sarcopenia on hospitalization costs. Eur J Clin Nutr2016; 70: 1046–1051.
8.
CleggAYoungJIliffeS, et al. Frailty in elderly people. Lancet2013; 381: 752–762.
9.
WoodsNFLaCroixAZGraySL, et al. Frailty: emergence and consequences in women aged 65 and older in the Women’s Health Initiative Observational Study. J Am Geriatr Soc2005; 53: 1321–1330.
10.
MakaryMASegevDLPronovostPJ, et al. Frailty as a predictor of surgical outcomes in older patients. J Am Coll Surg2010; 210: 901–918.
11.
Garonzik-WangJMGovindanPGrinnanJW, et al. Frailty and delayed graft function in kidney transplant recipients. Arch Surg2012; 147: 190–193.
12.
ArikGVaranHDYavuzBB, et al. Validation of Katz index of independence in activities of daily living in Turkish older adults. Arch Gerontol Geriatr2015; 61: 344–350.
13.
YesavageJABrinkTLRoseTL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res1982; 17: 37–49.
14.
CharlsonMEPompeiPAlesKL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis1987; 40: 373–383.
15.
FriedL.Conference on the physiologic basis of frailty. April 28, 1992, Baltimore, Maryland, USA introduction. Aging1992; 4: 251–252.
16.
VaranHDDenizOÇöteliS, et al. Validity and reliability of Fried frailty phenotype in Turkish population. Turk J Med Sci2022; 52: 323–328.
17.
Cruz-JentoftAJBahatGBauerJ, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing2019; 48: 16–31.
18.
BahatGTufanATufanF, et al. Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition. Clin Nutr2016; 35: 1557–1563.
19.
KuyumcuMEHalilMKaraO, et al. Ultrasonographic evaluation of the calf muscle mass and architecture in elderly patients with and without sarcopenia. Arch Gerontol Geriatr2016; 65: 218–224.
20.
DurmazBSoysalPEllidokuzH, et al. Validity and reliability of geriatric depression scale-15 (short form) in Turkish older adults. North Clin Istanb2018; 5: 216–220.
21.
HaysRDKallichJDMapesDL, et al. Development of the kidney disease quality of life (KDQOL TM) instrument. Qual Life Res. 1994; 3: 329–338.
22.
YıldırımAOgutmenBBektasG, et al. Translation, cultural adaptation, initial reliability, and validation of the Kidney Disease and Quality of Life–Short Form (KDQOL-SF 1.3) in Turkey. Transplant Proc2007; 39: 51–54.
23.
CookWJassalS.Functional dependencies among the elderly on hemodialysis. Kidney Int2008; 73: 1289–1295.
24.
JohansenKLChertowGMDa SilvaM, et al. Determinants of physical performance in ambulatory patients on hemodialysis. Kidney Int2001; 60: 1586–1591.
25.
ČengičBResicH.Depression in hemodialysis patients. Bosn J Basic Med Sci2010; 10: S73.
26.
CukorDPetersonRACohenSD, et al. Depression in end-stage renal disease hemodialysis patients. Nat Clin Pract Nephrol2006; 2: 678–687.
27.
HinrichsenGALiebermanJAPollackS, et al. Depression in hemodialysis patients. Psychosomatics1989; 30: 284–289.
28.
LeeH-JSonY-J.Prevalence and associated factors of frailty and mortality in patients with end-stage renal disease undergoing hemodialysis: a systematic review and meta-analysis. Int J Environ Res Public Health2021; 18: 3471.
29.
SalterMLGuptaNMassieAB, et al. Perceived frailty and measured frailty among adults undergoing hemodialysis: a cross-sectional analysis. BMC Geriatr2015; 15: 1–7.
30.
TakeuchiHUchidaHAKakioY, et al. The prevalence of frailty and its associated factors in Japanese hemodialysis patients. Aging Dis2018; 9: 192.
31.
ShuXLinTWangH, et al. Diagnosis, prevalence, and mortality of sarcopenia in dialysis patients: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle2022; 13: 145–158.
32.
KittiskulnamPCarreroJJChertowGM, et al. Sarcopenia among patients receiving hemodialysis: weighing the evidence. J Cachexia Sarcopenia Muscle2017; 8: 57–68.
33.
KimJ-KKimSGOhJ-E, et al. Impact of sarcopenia on long-term mortality and cardiovascular events in patients undergoing hemodialysis. Korean J Intern Med2017; 34: 599.
34.
CesariMRollandYAbellan Van KanG, et al. Sarcopenia-related parameters and incident disability in older persons: results from the “invecchiare in Chianti” study. J Gerontol A Biol Sci Med Sci2015; 70: 457–463.
35.
TanimotoYWatanabeMSunW, et al. Association of sarcopenia with functional decline in community-dwelling elderly subjects in Japan. Geriatr Gerontol Int2013; 13: 958–963.
36.
ChengDZhangQWangZ, et al. Association between sarcopenia and its components and dependency in activities of daily living in patients on hemodialysis. J Ren Nutr2021; 31: 397–402.
37.
HayashiTUmegakiHMakinoT, et al. Association between sarcopenia and depressive mood in urban-dwelling older adults: a cross-sectional study. Geriatr Gerontol Int2019; 19: 508–512.
38.
PascoJASuiSXWestEC, et al. Operational definitions of sarcopenia should consider depressive symptoms. JCSM Clin Rep2021; 6: 62–68.
39.
GoSWChaYHLeeJA, et al. Association between sarcopenia, bone density, and health-related quality of life in Korean men. Korean J Fam Med2013;34:281.
40.
GiglioJKamimuraMALamarcaF, et al. Association of sarcopenia with nutritional parameters, quality of life, hospitalization, and mortality rates of elderly patients on hemodialysis. J Ren Nutr2018; 28: 197–207.
41.
JafariMKourKGiebelS, et al. The burden of frailty on mood, cognition, quality of life, and level of independence in patients on hemodialysis: Regina Hemodialysis Frailty Study. Can J Kidney Health Dis2020; 7:1–11.
42.
YaoLYinLLiuF.P1512 The relationship among anxiety, depression and frailty in maintenance hemodialysis patient. Nephrol Dial Transplant2020; 35: gfaa142.
